The Society for Innovation and Entrepreneurship (SINE), the startup incubator at IIT Bombay, has announced an exciting new initiative—a Rs 100 crore venture capital (VC) fund aimed at supporting deeptech startups in critical sectors like science, biotechnology, space, and defense. This move is part of SINE’s broader strategy to scale up its support for innovation and entrepreneurship in…
India’s pharmaceutical landscape is evolving rapidly, with significant contributions to global healthcare highlighted at the 21st Indo-US Economic Summit. Rajeev Juneja, Vice Chairman and Managing Director of Mankind Pharma, emphasized the nation’s role in producing affordable, high-quality medicines, stating, “Every fourth tablet consumed globally is made in India. We have come a long way…
JAMMU: Union Minister Dr. Jitendra Singh emphasized on Sunday that the startup potential in Jammu and Kashmir (J&K) has yet to be fully tapped. Speaking at a Volunteers and Influencers Meet organized by the Social Media department of the Jammu & Kashmir BJP, he noted that while the startup movement in the region started relatively late, it is poised for rapid growth in the coming years.
Dr. Singh…
Abolis Biotechnologies, a pioneering French startup specializing in microbial solutions for industrial applications, has successfully raised €35 million in a new funding round. This investment is led by a consortium of prominent international investors, including BOLD, L’Oréal’s venture capital fund, Evonik Venture Capital, and several impact-focused funds such as DeepTech & Climate Fonds…
Chai Discovery, a nascent AI-driven biology startup, has secured nearly $30 million in funding from prominent investors Thrive Capital and OpenAI. Founded just six months ago, Chai aims to revolutionize drug discovery by utilizing AI to predict the structure of biochemical molecules and manipulate their interactions, a critical step in developing new medications.
Joshua Meier, the company’s…
Biocon, a leading biotechnology firm, announced a dramatic increase in its consolidated profit after tax for the first quarter ending June 2024. The company’s profit surged more than six times to ₹660 crore, driven by a significant one-time gain resulting from its collaboration with Eris Lifesciences through Biocon Biologics.
The substantial profit growth highlights the impact of strategic…
